Quantcast

Industry news that matters to you.  Learn more

Study: PET Biomarker Gets Validation for Alzheimer’s Disease

18F-Flutemetamol performs similarly to the 11C-Pittsburgh compound B (11C-PIB) parent molecule within the same subjects and provides high test-retest replicability and potentially much wider accessibility for clinical and research use for Alzheimer’s disease, based on a study in the September issue of the Annals of Neurology.